Bioprocess development services and the decisions that are hard to reverse later: staging upstream and downstream work so a process will actually transfer to the site that makes it, where upstream bioprocessing choices constrain everything after them, what a bioreactor system, a batch bioreactor, a bioreactor control system and bioprocess control generally have to deliver before a bioreactor cost comparison means anything, what a perfusion bioreactor, perfusion systems and perfusion culture buy over fed batch and what they cost in perfusion media and control, when single use systems, single use technology and single use systems in bioprocessing are genuinely cheaper than stainless once a single use assembly, single use assemblies, single use bioreactor bags, bioreactor bags, single use bags for pharmaceuticals, single use tubing, bioprocess tubing, chromatography tubing, single use valves, a single use valve, a single use mixer, a single use centrifuge or the decision to buy centrifuge capacity outright, single use chromatography, a single use chromatography system and a single use fermentor are all counted, how diafiltration and the tff equipment behind it decide buffer consumption and product quality, and what tff systems, a tff system, tff cassettes and a tff filter should be specified on before a vendor is chosen

Sequencing the decisions

1. Fix the culture mode against the product's stability. Fed batch is simpler, better understood and adequate for stable molecules. Perfusion keeps residence time short, which protects labile products and raises volumetric productivity, at the cost of far more media, more complex control and a harder technology transfer. Choose from the molecule, not from fashion.
2. Decide single use or stainless as a facility decision. Disposable assemblies remove cleaning validation and shorten changeover, which suits multiproduct facilities and clinical scale. Stainless wins on consumable cost at large scale and sustained campaigns. The break even depends on batch size and campaign frequency, so model your own numbers rather than trusting a generic curve.
3. Design the filtration train around buffer volume. Concentration and buffer exchange dominate buffer consumption, tank capacity and processing time. Sizing the membrane area and the number of exchange volumes early tells you whether the facility can support the process, and it frequently sends people back to an earlier step.
4. Watch shear and product quality across the train. Pumps, valves and recirculation through a membrane all impose shear, and labile products aggregate. Screen the sensitive steps at small scale with the actual product rather than a surrogate, because aggregation discovered at pilot scale is expensive.
5. Qualify the disposables as materials, not as hardware. Extractables and leachables, film compatibility, gamma dose and supply continuity are material questions attached to every disposable component. A single sole sourced component can stop a campaign, so map the supply chain while the process is still flexible.
6. Define the process description that will transfer. Critical parameters with ranges, in process controls, hold times and acceptance criteria, written so a receiving site can run it. A process that exists only as the habits of the people who developed it does not transfer, whatever the batch records say.

The disposables decision is really a facility decision

Choosing disposable assemblies removes clean in place and steam in place systems, the validation that goes with them and much of the changeover time between products. It adds a recurring consumable bill, a warehouse requirement and a dependency on suppliers whose lead times are outside your control.

The question to model is not which is cheaper per batch but which fits the facility you will actually operate: how many products, how many campaigns a year, what batch size, and how much floor area exists for storing what arrives in boxes.

Buffer volume is the hidden constraint

Diafiltration consumes buffer in multiples of the retentate volume, and every exchange volume has to be made, held, filtered and eventually disposed of. Facilities are frequently limited by buffer preparation and tank capacity rather than by bioreactor volume, and this is discovered during scale up rather than during development.

Calculating total buffer demand early, including hold tanks and the preparation schedule, is one of the highest value calculations in process development and one of the most frequently deferred.

What makes a process transferable

A parameter list with ranges rather than setpoints. Analytical methods described well enough to run elsewhere. In process controls with acceptance criteria. Hold times justified by data. A clear statement of what has been demonstrated at what scale.

Write these as the process develops rather than at the end. Reconstructing the justification for a parameter range from old notebooks is slow and sometimes impossible, and the receiving site will ask.

Common questions

When does single use stop being cheaper?

At large batch sizes with sustained campaigns, where the recurring consumable cost outweighs the cleaning and changeover savings. At clinical scale, in multiproduct facilities and where changeover speed matters, disposables usually win on total cost.

How is membrane area sized?

From the volume to process, the permeate flux the product allows and the time available, then confirmed experimentally because flux depends on the feed and fouls over time. Sizing from a supplier's nominal flux alone routinely underestimates the area required.

Is perfusion worth the complexity?

For unstable products and for intensified processes with high volumetric demand, yes. For stable molecules at moderate demand it adds media cost, control complexity and transfer risk without a proportionate return.

What should be locked before a clinical campaign?

The culture mode, the purification sequence, the critical parameters and the analytical methods. Changing any of those later triggers a comparability exercise, which costs more than getting them settled while the process is still cheap to change.

Browse by service class

• Compare Gene synthesis on advertised prices